Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
16,284,415
-
Shares change
-
+172,040
-
Total reported value, excl. options
-
$269,598,973
-
Value change
-
+$7,820,714
-
Number of buys
-
41
-
Number of sells
-
-20
-
Price
-
$16.54
Significant Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q1 2019
72 filings reported holding CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 as of Q1 2019.
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,284,415 shares
of 53,041,500 outstanding shares and own 31% of the company stock.
Largest 10 shareholders include FMR LLC (3,284,572 shares), Polaris Venture Management Co. V, L.L.C. (2,552,626 shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1,631,248 shares), Canaan Partners VIII LLC (1,618,141 shares), JENNISON ASSOCIATES LLC (1,249,904 shares), CANNELL CAPITAL LLC (626,975 shares), Voya Investment Management LLC (521,238 shares), VANGUARD GROUP INC (516,921 shares), BlackRock Inc. (465,404 shares), and WELLINGTON MANAGEMENT GROUP LLP (391,802 shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.